Skip to main content
. 2016 Apr 25;49(1):89–98. doi: 10.3892/ijo.2016.3496

Table I.

The combination index for ubenimex combined with anticancer drugs.

Cell line 5-FU CDDP DXR SOR
HuH7 0.49±0.36 0.59±0.13 0.68±0.13 1.17±0.18
PLC/PRF/5 0.64±0.28 0.59±0.16 0.70±0.10 0.92±0.10

5-FU, 5-fluorouracil; CDDP, cisplatin; DXR, doxorubicin; SOR, sorafenib. Data are expressed as mean ± SD.